Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
Apply
Amivantamab & Lazertinib, Amivantamab & Chemotherapy
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step